Evommune EVMN
NYSE EVMN
$5.18 -0.20 (-3.72%)
As of: Oct 21, 2026 · 3:59 PM EDT

Evommune (EVMN) Payables (2024 - 2026)

Updated

Evommune (EVMN) posted Payables of $5.04 million for Q2 2026, up 24.7% from the prior quarter.

Analysis

Evommune (EVMN) Payables (2024 - 2026) Analysis & Trends

At the end of FY2025, Evommune's Payables came in at $7.76 million, down 6.1% from FY2024.

  • In prior years, Evommune's Payables was $8.26 million in FY2024.
  • Quarterly Payables has run from a low of $3.58 million in Q3 2025 to a high of $8.26 million in Q4 2024 over five years.
  • According to Business Quant data, Payables for the three prior quarters was $4.05 million (Q1 2026), $7.76 million (Q4 2025) and $3.58 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 20.92 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 33.30 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.96 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 22.89 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 674.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 7.03 Bn
10 Evommune 186.46 Mn -451.06 Mn - 5.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.04 Mn
Mar 31, 2026 4.05 Mn
Dec 31, 2025 7.76 Mn
Sep 30, 2025 3.58 Mn
Dec 31, 2024 8.26 Mn
API Access

Evommune Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=EVMN&period=max&api_key=YOUR_API_KEY